241
Views
2
CrossRef citations to date
0
Altmetric
Original Papers

‘HIV has a woman's face’: vaginal microbicides and a case of ambiguous failure

Pages 250-262 | Received 12 Jun 2015, Accepted 24 Jul 2015, Published online: 06 Oct 2015

References

  • Abdool Karim, S., B. A. Richardson, G. Ramjee, I. Hoffman, M. Chirenje, T. Taha, M. Kapina. 2011. “Safety and Effectiveness of BufferGel and 0.5% PRO2000 Gel for The Prevention of HIV Infection in Women.” Aids 25: 957–966.
  • Annan, K. 2002. “In Africa, AIDS Has a Woman's Face. New York Times, December 29.
  • Biruk, C. 2011. “Seeing Like a Research Project: Producing “High-Quality Data” in AIDS Research in Malawi.” Medical Anthropology 31 (4): 347–366.
  • Crook, A. M., and A. J. Nunn. 2012. “Statistical and Methodological Issues in Microbicide Trial Design.” Best Practice & Research Clinical Obstetrics & Gynaecology 26 (4): 463–471.
  • Fairhead, J., M. Leach, and M. Small. 2006. “Where Techno-Science Meets Poverty: Medical Research and the Economy of Blood in The Gambia, West Africa.” Social Science & Medicine 63: 1109–1120.
  • Ferrer, R. A., K. M. Morrow, W. A. Fisher, J. D. Fisher. 2010. “Toward an Information-Motivation-Behavioral Skills Model of Microbicide Adherence in Clinical Trials.” Aids Care-Psychological and Socio-Medical Aspects of Aids/Hiv 22 (8): 997–1005.
  • Forbes, A. 2013. “Mobilizing Women at the Grassroots to Shape Health Policy: A Case Study of the Global Campaign for Microbicides.” Reproductive Health Matters 21 (42): 174–183.
  • Geissler, P. W., and R. Pool. 2006. “Editorial: Popular Concerns About Medical Research Projects in Sub-Saharan Africa - A Critical Voice in Debates About Medical Research Ethics.” Tropical Medicine & International Health 11 (7): 975–982.
  • Global Campaign for Microbicides. 2007. “Who's Who in the Microbicides Field: An Annotated Summary.”
  • Grant, R. M., D. Hamer, T. Hope, R. Johnston, J. Lange, M. M. Lederman, J. Lieberman. 2008. “Whither or Wither Microbicides?” Science 321 (5888): 532–534.
  • Greenhead, P., P. Hayes, P. S. Watts, K. G. Laing, G. E. Griffin, R. J. Shattock. 2000. “Parameters of Human Immunodeficiency Virus Infection of Human Cervical Tissue and Inhibition by Vaginal Virucides.” Journal Virologica 74 (12): 5577–5586.
  • HIV Vaccines and Microbicides Resource Tracking Working Group. 2011. Funding for Microbicide R&D in 2010. Available at: http://www.hivresourcetracking.org/sites/default/files/MicrobicideFunding20101-pager.pdf.
  • Keller, M. J., P. M. M. Mesquita, N. M. Torres, S. Cho, G. Shust, R. P. Madan, H. W. Cohen. 2010. “Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials.” Plos One 5 (1):e8781.
  • Kim, K. A., M. Yolamanova, O. Zirafi, N. R. Roan, L. Staendker, W. G. Forssmann, A. Burgener. 2010. “Semen-Mediated Enhancement of HIV Infection is Donor-Dependent and Correlates With the Levels of SEVI.” Retrovirology 7: 55.
  • Kingori, P., M. Muchimba, B. Sikateyo, B. Amadi, P. Kelly. 2010. “‘Rumours’ and Clinical Trials: A Retrospective Examination of a Paediatric Malnutrition Study in Zambia, Southern Africa.” BMC Public Health 10: 556.
  • Lampland, M. 2010. “False Numbers as Formalizing Practices.” Social Studies of Science 40 (3): 377–404.
  • Law, J. 2004. After Method. Mess in Social Science Research. London & New York: Routledge.
  • Lynch, M. 2013. “Ontography: Investigating the Production of Things, Deflating Ontology.” Social Studies of Science 43 (3): 444–462.
  • Mâsse, B. R., M. C. Boily, D. Dobromir, D. Kamal. 2009. “Efficacy dilution in randomized placebo-controlled vaginal microbicide trials.” Emerging Themes in Epidemiology 6 (5).
  • Mauck, C. K., and J. L. Schwartz. 2012. “Dyeing to Know: The Use of Vaginal Applicator Staining and Other Techniques to Assess Adherence to Product Use in Microbicide Trials.” Sexually Transmitted Diseases 39 (9): 713–715.
  • McCormack, S., G. Ramjee, A. Kamali, H. Rees, A.M. Crook, M. Gafos, U. Jentsch. 2010. “PRO2000 Vaginal Gel for Prevention of HIV-1 Infection (Microbicides Development Programme 301): A Phase 3, Randomised, Double-Blind, Parallel-Group Trial.” Lancet 376 (9749): 1329–1337.
  • McGowan, I. 2010. “Microbicides for HIV Prevention: Reality or Hope?” Current Opinion in Infectious Diseases 23 (1): 26–31.
  • McGowan, I., and D. J. Taylor. 2010. “Heterosexual anal Intercourse Has the Potential to Cause a Significant Loss of Power in Vaginal Microbicide Effectiveness Studies.” Sex Transmitted Diseases 37 (6): 361–364.
  • Microbicides Development Programme. 2009. “HIV ‘prevention’ gel PRO 2000 proven ineffective. http://www.mdp.mrc.ac.uk/archive.html. ( Accessed 02 March 2012).
  • Mol, A. 2003. The Body Multiple: Ontology in Medical Practice. Durham: Duke University Press.
  • Montgomery, C. M. 2012. “Making Prevention Public: The Co-Production of Gender and Technology in HIV Prevention Research.” Social Studies of Science 42 (6): 922–944.
  • Montgomery, C. M., and R. Pool. Forthcoming. Experimental Publics: Trials and Transience in Zambia.
  • Montgomery, C. M., M. Gafos, S. Lees, N. S. Morar, O. Mweemba, A. Ssali, J. Stadler, R. Pool. 2010. “Re-Framing Microbicide Acceptability: Findings From the MDP301 Trial.” Culture, Health & Sexuality 12 (6): 649–662.
  • Morey, T. E., S. Wasdo, J. Wishin, B. Quinn, A. van der Straten, M. Booth, D. Gonzalez, H. Derendorf, R. J. Melker, D. M. Dennis. 2013. “Feasibility of a Breath Test for Monitoring Adherence to Vaginal Administration of Antiretroviral Microbicide Gels.” Journal of Clinical Pharmacology 53 (1): 103–111.
  • Nunn, A., S. McCormack, A. M. Crook, R. Pool, C. Rutterford, R. Hayes. 2009. “Microbicides Development Programme: Design of a Phase III Trial to Measure the Efficacy of the Vaginal Microbicide PRO 2000/5 for HIV Prevention.” Trials 10: 99.
  • Peeters Grietens, K., J. M. Ribera, A. Erhart, S. Holbak, R. M. Ravinetto, C. Gryseels, S. Dierickx, S. O'Neill, S. H. Muela, U. D'Alessandro. 2014. “Doctors and Vampires in Sub-Saharan Africa: Ethical Challenges in Clinical Trial Research.” The American Journal of Tropical Medicine and Hygiene 91 (2): 213–215.
  • Ragin, C. C. 1992. ““Casing” and The Process of Social Inquiry.” In What is a Case? Exploring the Foundations of Social Inquiry. edited by C. C. Ragin and H. S. Becker, 217–226. Cambridge: Cambridge University Press.
  • Skoler-Karpoff, S., G. Ramjee, K. Ahmed, L. Altini, M. G. Plagianos, B. Friedland, S. Govender. 2008. “Efficacy of Carraguard for Prevention of HIV Infection in Women in South Africa: A Randomised, Double-Blind, Placebo-Controlled Trial.” The Lancet 372 (9654): 1977–1987.
  • Stadler, J., and E. Saethre. 2011. “Blockage and Flow: Intimate Experiences of Condoms and Microbicides in a South African Clinical Trial.” Culture, Health & Sexuality 13 (1): 31–44.
  • Stadler, J., S. Delany-Moretlwe, T. Palanee, H. Rees. 2014. “Hidden Harms: Women's Narratives of Intimate Partner Violence in a Microbicide Trial, South Africa.” Social Science & Medicine 110: 49–55.
  • Star, S., and J. Griesemer. 1989. “Institutional Ecology, ‘Translations’ and Boundary Objects: Amateurs and Professionals in Berkeley's Museum of Vertebrate Zoology.” Social Studies of Science 19 (3): 387–420.
  • Stein, Z. A. 1990. “HIV Prevention: The Need for Methods Women Can Use.” American Journal of Public Health 80 (4): 460–462.
  • Tan, S., L. Lu, L. Li, J. Liu, Y. Oksov, H. Lu, S. Jiang, S. Liu. 2013. “Polyanionic Candidate Microbicides Accelerate the Formation of Semen-Derived Amyloid Fibrils to Enhance HIV-1 Infection.” Plos One 8 (3): e59777.
  • Terblanche, D. 2009. “The gel of hope. Zululand Fever. Richards Bay, South Africa.
  • Turner, A. N., A. E. De Kock, A. Meehan-Ritter, K. Blancharda, M. H. Sebolad, A. A. Hoosend, N. Coetzeeb, C. Ellertson. 2009. “Many Vaginal Microbicide Trial Participants Acknowledged They had Misreported Sensitive Sexual Behavior in Face-to-Face Interviews.” Journal of Clinical Epidemiology 62 (7): 759–765.
  • Uprichard, E. 2013. “Sampling: Bridging Probability and Nonprobability Designs.” International Journal of Social Research Methodology 16 (1): 1–11.
  • Van Damme, L., R. Govinden, F. M. Mirembe, F. Guedou, S. Solomon, M. L. Becker, B. S. Pradeep. 2008. “Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission.” New England Journal of Medicine 359 (5): 463–472.
  • van der Straten, A., H. Cheng, S. Wasdo, L. Montgomery, K. Smith-McCune, M. Booth, D. Gonzalez, H. Derendorf, T. E. Morey, D. M. Dennis. 2013. “A Novel Breath Test to Directly Measure Use of Vaginal Gel and Condoms.” Aids and Behavior 17 (6): 2211–2221.
  • Weber, J., A. Nunn, T. O'Connor, D. Jeffries, V. Kitchen, S. McCormack, J. Stott, N. Almond, A. Stone, J. Derbyshire. 2001. “‘Chemical Condoms’ for the Prevention of HIV Infection: Evaluation of Novel Agents Against SHIV89.6PD in Vitro and in Vivo.” Aids 15 (12): 1563–1568.
  • Zirafi, O., K.-A. Kim, N. R. Roan, S. F. Kluge, J. A. Mueller, S. Jiang, B. Mayer, W. C. Greene, F. Kirchhoff, J. Muench. 2014. “Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.” Science Translational Medicine 6 (262): 262ra157.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.